Neko Health, co-founded by Spotify's Daniel Ek, operates clinics offering a rapid full-body scan that captures thousands of health data points for preventive screening.
Healthcare📍 Stockholm, SwedenFounded 2018
Current Valuation
$1.8B
as of 2025
UNICORN
QL Price
$1.8B
0% vs last round
QuantLogix's current estimate for Neko Health, published 2026-09-21 — in line with the last disclosed round of $1.8B (2026-07).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.8B
2026-07
weight 0.86
Secondary market print
$1.8B
2026-06-27
weight 0.6
How this price has held up
No round has priced for Neko Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-21 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Neko Health, 2026-09-21 (c91d87507548408d).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Neko Health going public?
No. Neko Health is private and has not filed to go public. There is no S-1 on file.
What is Neko Health's valuation in 2026?
Neko Health is valued at $1.8B as of 2025. That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Neko Health filed an S-1?
No public S-1 is on file for Neko Health.
Can you buy Neko Health stock?
No. Neko Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Neko Health on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2018
HQ
Stockholm, Sweden
IPO Status
private
Fundraising Status
private
Secondary Market
Implied price / share
$5
Open interest
1
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Talent Signal
Hiring trend
▶ Hiring steady
-2% vs 2026-08
Open roles
105
via ashby
Product-build share
48%
engineering, research, product, design
Trajectory
steady
product-led hiring — 48% of open roles build product; the rest are go-to-market and G&A.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
System Verification Engineer, Test AutomationClinical Development Lead, AI/LLMOptics EngineerField Service EngineerSenior Research SonographerQuality Program Manager
Counted from Neko Health's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Daniel EkHjalmar Nilsonne
Products
Full-body preventive health scan
Competitors
Function Health · Prenuvo
HealthcarePreventive HealthDiagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025. Refreshed quarterly.